Account
Inquiry
Tirzepatide, known by its research code LY3298176, is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It is primarily utilized in research settings for studying type 2 diabetes and weight management mechanisms. The tirzepatide 15mg formulation offers a high-purity option for laboratory use, ensuring consistent and reliable results in experimental protocols.
This peptide exhibits a molecular formula of C225H348N48O68 and appears as a white powder. Its structure includes a lys side chain with PEG modification, enhancing water solubility and functional efficacy. Research indicates that tirzepatide 15mg demonstrates superior glucose control and weight reduction compared to selective GLP-1 receptor agonists, making it a valuable compound for metabolic studies.
In clinical research contexts, tirzepatide has shown promising outcomes in weight loss trials, with significant reductions observed in overweight subjects. The SURMOUNT-1 trial highlighted an average weight loss of 20.9% with the tirzepatide 15mg dose over 72 weeks. These findings underscore its potential in obesity and diabetes-related research, though it is strictly for investigational purposes and not for personal use.
Our supply includes tirzepatide 15mg vials, packaged securely to maintain integrity and purity. Each vial contains 15mg of peptide, with options for bulk quantities and custom packaging to meet specific research needs. Proper storage is essential: keep in a cold, dry, dark place, avoid repeated freezing/thawing, and minimize exposure to air and light to preserve stability.
For research institutions and laboratories, we provide tirzepatide 15mg with comprehensive support, including batch documentation and purity reports. Our products are manufactured under strict quality controls to ensure they meet the demands of scientific inquiry. Inquire for pricing and bulk order details tailored to your project requirements.
